Autres langues BioVaxys Technology Corp.

Actions

BIOV

CA09076M1014

Marché Fermé - Canadian Securities Exchange Autres places de cotation 21:35:54 15/05/2024			Varia. 5j.	Varia. 1 janv.
0,07 ^CAD	-12,50%		-12,50%	+40,00%

10/04	Biovaxys et SpayVac-For-Wildlife, Inc. annoncent le lancement d'un essai sur le terrain pour l'immunocontraception à grande échelle dans l'industrie de l'élevage aquatique commercial	CI
03/04	BioVaxys annonce l'autorisation du brevet de formulation DPX pour les Etats-Unis et le dépôt de demandes de brevets internationaux supplémentaires pour la phase 1 de DPX SurMage	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioVaxys Technology Corp. Announces Failure to File Cease Trade Order	16/05
CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV)	16/05
Canadian Investment Regulatory Organization Trading Halt - BIOV	16/05
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement	10/05
BioVaxys Technology Corp. Closes First Tranche of Private Placement	04/05
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	02/05
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050	01/05
BioVaxys Technology Corp. Appoints Christopher Cherry as Chief Financial Officer	30/04
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	18/04
Biovaxys and SpayVac-For-Wildlife, Inc. Announce Launch of Field Trial for Large-Scale Immunocontraception in the Commercial Aquatic Farming Industry	10/04
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY	10/04
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	05/04
BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMage	03/04
BioVaxys Technology Plans Private Placement; Down 5.9%	25/03
BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT	22/03
BioVaxys Technology Corp. announced that it expects to receive CAD 1 million in funding	22/03
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	21/03
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	07/03
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update	07/03
BioVaxys Technology Corp. Announces Allowance of DPX-Related Patent for Japan and Filing of Additional International Patent Applications	05/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BioVaxys Technology Corp.

Actions

BIOV

CA09076M1014

Autres langues

Filtres